Organon, a biopharmaceutical company with co-headquarters in Oss, the Netherlands, and Roseland, NJ, is focused on developing breakthrough medicines in gynecology, fertility, neuroscience and anesthesia.

The company's leading biologics are:

Follistim (follitropin). Puregon, a recombinant follicle-stimulating hormone, is a pure gonadotropin widely used to treat infertility. In the decade that the biologic has been available, an estimated one million children have been born following assisted reproduction treatment with Follistim.

Pregnyl (human chorionic gonadotropin). Pregnyl, a highly purified preparation of human chorionic gonadotropin obtained from the urine of pregnant women, mimics the normal surge of luteinizing hormone that occurs mid-way through a normal menstrual cycle, and causes ovulation to begin.

*Information above taken from materials provided by Organon.